Taxation (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of Loss Before Income Tax Expense (Benefits) |
Loss before income tax expenses (benefits) for the years ended December 31, 2023, 2024 and 2025 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For the Year Ended December 31, |
|
| |
|
|
|
|
2024 |
|
|
|
|
PRC |
|
|
(11,024,653 |
) |
|
|
(6,038,105 |
) |
|
|
(1,499,539 |
) |
Other jurisdictions |
|
|
630,948 |
|
|
|
207,130 |
|
|
|
342,736 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income tax expenses (benefits) |
|
|
(10,393,705 |
) |
|
|
(5,830,975 |
) |
|
|
(1,156,803 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Composition of Income Tax Expenses |
Composition of income tax expenses (benefit) for the years presented are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
For the Year Ended December 31, |
|
| |
|
|
|
|
|
|
|
|
|
Current income tax expenses |
|
|
|
|
|
|
|
|
|
|
|
|
PRC |
|
|
4,044 |
|
|
|
456 |
|
|
|
13,372 |
|
Other jurisdictions |
|
|
13,970 |
|
|
|
21,841 |
|
|
|
19,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current |
|
|
18,014 |
|
|
|
22,297 |
|
|
|
33,368 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred income tax expenses (benefit) |
|
|
|
|
|
|
|
|
|
|
|
|
PRC |
|
|
18,151 |
|
|
|
(91,432 |
) |
|
|
(19,783 |
) |
Other jurisdictions |
|
|
645 |
|
|
|
(645 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred |
|
|
18,796 |
|
|
|
(92,077 |
) |
|
|
(19,783 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expenses (benefit) |
|
|
36,810 |
|
|
|
(69,780 |
) |
|
|
13,585 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Reconciliations of the Income Tax Expenses |
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2(z), Summary of Significant Accounting Policies, the reconciliation of taxes at the statutory rate to our income taxes for the year ended December 31, 2025 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax credit computed at the PRC statutory income tax rate of 25% (i) |
|
|
(289,201 |
) |
|
|
25.0 |
% |
Other jurisdictions taxes effect |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statutory tax rate difference between Cayman and Chinese Mainland |
|
|
(322,695 |
) |
|
|
27.9 |
% |
British Virgin Islands (“BVI”) |
|
|
|
|
|
|
|
|
Statutory tax rate difference between BVI and Chinese Mainland |
|
|
(77,859 |
) |
|
|
6.7 |
% |
|
|
|
|
|
|
|
|
|
Statutory tax rate difference between Hong Kong and Chinese Mainland |
|
|
80,115 |
|
|
|
-6.9 |
% |
Nontaxable or nondeductible items |
|
|
|
|
|
|
|
|
Unrealized Foreign Exchange Gain or Loss |
|
|
137,107 |
|
|
|
-11.9 |
% |
|
|
|
490 |
|
|
|
0.0 |
% |
Changes in valuation allowances |
|
|
17,921 |
|
|
|
-1.5 |
% |
|
|
|
|
|
|
|
|
|
Changes in valuation allowances |
|
|
61,360 |
|
|
|
-5.3 |
% |
|
|
|
(7,268 |
) |
|
|
0.6 |
% |
|
|
|
45,142 |
|
|
|
-3.9 |
% |
Changes in valuation allowances |
|
|
1,605,178 |
|
|
|
-138.8 |
% |
Nontaxable or nondeductible items |
|
|
|
|
|
|
|
|
Share-based compensation expenses |
|
|
90,216 |
|
|
|
-7.8 |
% |
Effect of additional deduction for qualified R&D expenses |
|
|
(854,918 |
) |
|
|
73.9 |
% |
Effect of preferential tax rates |
|
|
(469,989 |
) |
|
|
40.6 |
% |
Other |
|
|
(2,014 |
) |
|
|
0.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
13,585 |
|
|
|
-1.2 |
% |
|
|
|
|
|
|
|
|
|
|
(i) |
The PRC statutory income tax rate is used because the majority of the Group’s operations are based in the PRC. | Reconciliations of the income tax expenses computed by applying the PRC statutory income tax rate of 25% to the Group’s income tax expenses of the years ended December 31, 2023 and 2024 in accordance with the guidance prior to the adoption of ASU 2023-09 presented are as follows:
|
|
|
|
|
|
|
|
|
| |
|
For the Year Ended December 31, |
|
| |
|
|
|
|
|
|
| Loss before income tax expenses (benefit) and share of results of equity method investees |
|
|
(10,393,705 |
) |
|
|
(5,830,975 |
) |
Income tax credit computed at the PRC statutory income tax rate of 25% (i) |
|
|
(2,598,426 |
) |
|
|
(1,457,744 |
) |
Effect of preferential tax rate (ii) |
|
|
29,362 |
|
|
|
29,108 |
|
| |
|
|
(33,657 |
) |
|
|
(9,110 |
) |
| Effect of change in tax rate |
|
|
(79,401 |
) |
|
|
1,054,824 |
|
| Effect of different tax rate of different jurisdictions |
|
|
114,036 |
|
|
|
(127,510 |
) |
| Effect of additional deduction for qualified R&D expenses |
|
|
(1,184,717 |
) |
|
|
(815,144 |
) |
| |
|
|
(230,127 |
) |
|
|
512,324 |
|
| |
|
|
(494,696 |
) |
|
|
150,721 |
|
| Changes in valuation allowance |
|
|
4,514,436 |
|
|
|
592,751 |
|
|
|
|
|
|
|
|
|
|
| Income tax expenses (benefit) |
|
|
36,810 |
|
|
|
(69,780 |
) |
|
|
|
|
|
|
|
|
|
| |
(i) |
The PRC statutory income tax rate is used because the majority of the Group’s operations are based in the PRC. |
| |
(ii) |
The effect of preferential tax rate resulted in a deduction of the income tax credit computed at the PRC statutory income tax rate of 25%. |
| |
(iii) |
Income tax credit amounting to RMB536,974 result from acquisition of subsidiaries was included in other adjustments for the years ended December 31, 2023. |
|
| Schedule of Cash Paid for Income Taxes Net of Refund |
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, as described in Note 2(z), Summary of Significant Accounting Policies, cash paid for income taxes, net of refunds, during the year ended December 31, 2025 was as follows:
|
|
|
|
|
|
|
For the Year Ended December 31, |
|
| |
|
|
3,012 |
|
| |
|
|
|
|
| |
|
|
5,777 |
|
| |
|
|
5,030 |
|
| |
|
|
1,505 |
|
| |
|
|
1,935 |
|
|
|
|
|
|
Cash paid for income taxes, net of refunds |
|
|
17,259 |
|
|
|
|
|
|
|
| Summary of Components of Deferred Tax Assets |
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| Net operating loss carry-forwards |
|
|
9,759,109 |
|
|
|
11,871,230 |
|
| Government grants |
|
|
33,719 |
|
|
|
37,151 |
|
| Impairment of long-lived assets |
|
|
43,592 |
|
|
|
38,462 |
|
| Inventory reserve |
|
|
81,922 |
|
|
|
113,168 |
|
| Accruals and others |
|
|
1,474,063 |
|
|
|
1,402,617 |
|
| Leases |
|
|
462,825 |
|
|
|
908,345 |
|
| Valuation allowance |
|
|
(10,870,573 |
) |
|
|
(12,879,997 |
) |
|
|
|
|
|
|
|
|
|
| Total deferred tax assets, net of valuation allowance |
|
|
984,657 |
|
|
|
1,490,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Leases |
|
|
(462,906 |
) |
|
|
(930,717 |
) |
Acquired intangible assets |
|
|
(833,393 |
) |
|
|
(715,368 |
) |
Others |
|
|
(298 |
) |
|
|
(137,049 |
) |
|
|
|
|
|
|
|
|
|
Total deferred tax liabilities |
|
|
(1,296,597 |
) |
|
|
(1,783,134 |
) |
|
|
|
|
|
|
|
|
|
Deferred tax assets, net |
|
|
29,992 |
|
|
|
38,195 |
|
Deferred tax liabilities, net |
|
|
(341,932 |
) |
|
|
(330,353 |
) |
|
| Summary of Movement in Valuation Allowance |
Movement of valuation allowance is as follow:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at beginning of the year |
|
|
5,763,386 |
|
|
|
10,277,822 |
|
|
|
10,870,573 |
|
Additions |
|
|
3,990,147 |
|
|
|
1,798,296 |
|
|
|
2,105,516 |
|
Acquisition of subsidiaries |
|
|
536,974 |
|
|
|
— |
|
|
|
— |
|
Loss expired |
|
|
(92,086 |
) |
|
|
(150,721 |
) |
|
|
(224,457 |
) |
Effect of change in tax rate |
|
|
79,401 |
|
|
|
(1,054,824 |
) |
|
|
128,365 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at end of the year |
|
|
10,277,822 |
|
|
|
10,870,573 |
|
|
|
12,879,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Summary of Tax Loss Carryforwards |
The Group has tax losses arising in Chinese Mainland of RMB51,061,235 that will expire in one to ten years for deduction against future taxable profits.
|
|
|
|
|
|
|
|
|
|
Loss expiring in 2026 |
|
|
2,167,601 |
|
Loss expiring in 2027 |
|
|
4,800,204 |
|
Loss expiring in 2028 |
|
|
9,633,770 |
|
Loss expiring in 2029 |
|
|
9,572,753 |
|
Loss expiring in 2030 |
|
|
9,573,305 |
|
Loss expiring in 2031 |
|
|
2,276,506 |
|
Loss expiring in 2032 |
|
|
3,974,361 |
|
Loss expiring in 2033 |
|
|
6,438,268 |
|
Loss expiring in 2034 |
|
|
1,985,264 |
|
Loss expiring in 2035 |
|
|
639,203 |
|
|
|
|
|
|
Total |
|
|
51,061,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong |
|
|
908,234 |
|
Others |
|
|
945,653 |
|
|
|
|
|
|
Total |
|
|
1,853,887 |
|
|
|
|
|
|
|